Santhera Pharmaceuticals Holding AG (LON:0QN1)

LON:0QN1 Revenue

Santhera Pharmaceuticals Holding AG had revenue of 24.01M CHF in the half year ending June 30, 2025, with 509.62% growth. This brings the company's revenue in the last twelve months to 49.02M, down -56.85% year-over-year. In the year 2024, Santhera Pharmaceuticals Holding AG had annual revenue of 39.12M, down -62.17%.

• Revenue (ttm): 49.02M CHF
• Revenue Growth: -56.85%
• P/S Ratio: 2.85
• Revenue / Employee: 624.41K CHF
• Employees: 79
• Market Cap: 128.35M GBP

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.12M	-64.30M	-62.17%
Dec 31, 2023	103.41M	95.94M	1,283.84%
Dec 31, 2022	7.47M	9.07M	-568.53%
Dec 31, 2021	-1.60M	-16.60M	-110.63%
Dec 31, 2020	15.01M	-60.37M	-80.09%